Results 181 to 190 of about 122,325 (212)
Some of the next articles are maybe not open access.

HCV-associated lymphomas.

Reviews in clinical and experimental hematology, 2003
Epidemiologic and molecular observations have recently suggested that hepatitis C virus (HCV) may be the causative agent of some B-cell non-Hodgkin lymphomas (B-NHL). Epidemiologic data suggest that in Italy about 5% of B-NHL are caused by HCV. Molecular data indicate a close relationship between HCV-associated B-NHL and type II mixed cryoglobulinemia.
FIORILLI, Massimo   +3 more
openaire   +4 more sources

HCV and hypogammaglobulinemia

Journal of Hepatology, 1997
F J, Sierra   +7 more
openaire   +2 more sources

Studying HCV Cell Entry with HCV Pseudoparticles (HCVpp)

2009
HCV infection leads in 50 to 80% of cases to chronic hepatitis, liver cirrhosis, or hepatocellular carcinoma. Interferons and the nucleoside analog ribavirin form the basis for treatment but are not sufficiently effective and have numerous side effects.
Birke, Bartosch, François-Loïc, Cosset
openaire   +2 more sources

HCV and lymphomagenesis

The Lancet, 1996
M. Galli   +4 more
openaire   +3 more sources

[HCV].

Rinsho byori. The Japanese journal of clinical pathology, 1994
HCV is an RNA-virus which contains a positive-strand RNA genome. The RT-PCR method is used to detect the HCV-RNA in plasma. Quantification of HCV-RNA is difficult, but it can now be done by a competitive RT-PCR method developed recently. Genotypes of HCV can be classified into at least six basic groups, genotype I-IV can be distinguished by RT-PCR with
H, Tsujii, M, Yoshikawa, H, Nakano
openaire   +1 more source

HCV Antigen in anti-HCV positive sera of patients with HCV infection

2002
Only ways to detect HCV viremia have beendetection of HCV RNA by nucleid acid amplifying test (NAT). Nats wew sensitive butentails substantial operational complexity and are very expensive for screening. Recently it was developed a sensitive EIA for HCVAg detection during a period when it is free, not bound with antibody, because they were not yet ...
openaire   +1 more source

?????????????????????? ???????????????????????? ?? ???????????????????????????????? ?????????????????? ???????????? ?????? HCV-????????????????

2012
???????????????????? ?????????? ?????????????????????????? ?? ???????????????????? ????????????????????, ???????????????????? ???????????????? ?????????????? ?????? ?????????????????? ???????????? HCV-????????????????. ???????????????? ?????????????????????? ???????????????????????????? ???????????????????????? ?????????? ????????????????????, ?????????
openaire   +1 more source

The oncologic burden of hepatitis C virus infection: A clinical perspective

Ca-A Cancer Journal for Clinicians, 2017
Harrys A Torres   +2 more
exaly  

Home - About - Disclaimer - Privacy